RecruitingNCT06129656
Cardiac Amyloidosis Registry of University Hospital Leipzig
Sponsor
University of Leipzig
Enrollment
500 participants
Start Date
May 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
Eligibility
Inclusion Criteria1
- Confirmed cardiac amyloidosis according to current standards
Exclusion Criteria1
- refusal to participate
Interventions
OTHERRoutine diagnostics
Data collection of routine diagnostics
OTHERRoutine treatment
Data collection of routine treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06129656
Related Trials
Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
NCT0642730436 locations
[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis
NCT072324592 locations
US Benchmarking Clinical Study
NCT072157153 locations
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease
NCT071543941 location
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
NCT071305652 locations